CROSSCARE enhances cancer diagnosis and treatment in the Romania-Serbia cross-border region, reducing mortality and improving patient outcomes through advanced diagnostics, personalised treatments, and state-of-the-art medical technology.

🔬 Using advanced medical equipment and an expanded Expert System Software (ESS), oncologists will conduct precise genetic and immunophenotypic testing for personalised therapies. Cutting-edge diagnostics like Next-Generation Sequencing (NGS), flow cytometry, and qRT-PCR will ensure accurate diagnoses.

Key benefits:
✅ Improved cancer care for 300 patients;
✅ Personalised treatments based on genetic testing and lack of toxicity;
✅ Collaboration between Romanian & Serbian institutions;
✅ State-of-the-art surgical procedures;
✅ New cross-border guidelines for precision medicine;

Findings will shape future healthcare policies in Romania and Serbia, transforming cancer care in the region!